The relationship between the modified National Institute of Health activity and chronicity scoring system, and the long-term prognosis for lupus nephritis: A retrospective single-center study.


Journal

Lupus
ISSN: 1477-0962
Titre abrégé: Lupus
Pays: England
ID NLM: 9204265

Informations de publication

Date de publication:
Oct 2021
Historique:
pubmed: 22 7 2021
medline: 9 2 2022
entrez: 21 7 2021
Statut: ppublish

Résumé

The revision of International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification guidelines for lupus nephritis (LN) was suggested by a working group, who recommended a modified National Institute of Health (NIH) activity and chronicity scoring system to evaluate active and chronic LN lesions. However, whether this approach was useful for estimating long-term prognosis for LN patients is unclear. We conducted a retrospective cohort study in Japanese subjects with biopsy-proven LN, between 1977 and 2018. Pathologic lesions were evaluated based on ISN/RPS 2003 classifications and the modified NIH scoring system. Patients were grouped by activity index (low, 0-5; moderate, 6-11; high, 12-24), and chronicity index (low, 0-2; moderate, 3-5; high, 6-12). The primary outcome was a composite of end-stage kidney disease (ESKD) or all-cause death, and the secondary outcome was ESKD alone. Sixty-six subjects with a median age of 31 years were included. During median follow-up (11.5 years), 15 patients reached the primary outcome: 10 had ESKD, four had died, and one had ESKD and died. Kaplan-Meier analysis showed that the cumulative primary outcome incidence increased with a higher chronicity index (log-rank trend Moderate and high chronicity indices were associated with an increased ESKD risk for LN.

Sections du résumé

BACKGROUND BACKGROUND
The revision of International Society of Nephrology/Renal Pathology Society (ISN/RPS) classification guidelines for lupus nephritis (LN) was suggested by a working group, who recommended a modified National Institute of Health (NIH) activity and chronicity scoring system to evaluate active and chronic LN lesions. However, whether this approach was useful for estimating long-term prognosis for LN patients is unclear.
METHODS METHODS
We conducted a retrospective cohort study in Japanese subjects with biopsy-proven LN, between 1977 and 2018. Pathologic lesions were evaluated based on ISN/RPS 2003 classifications and the modified NIH scoring system. Patients were grouped by activity index (low, 0-5; moderate, 6-11; high, 12-24), and chronicity index (low, 0-2; moderate, 3-5; high, 6-12). The primary outcome was a composite of end-stage kidney disease (ESKD) or all-cause death, and the secondary outcome was ESKD alone.
RESULTS RESULTS
Sixty-six subjects with a median age of 31 years were included. During median follow-up (11.5 years), 15 patients reached the primary outcome: 10 had ESKD, four had died, and one had ESKD and died. Kaplan-Meier analysis showed that the cumulative primary outcome incidence increased with a higher chronicity index (log-rank trend
CONCLUSION CONCLUSIONS
Moderate and high chronicity indices were associated with an increased ESKD risk for LN.

Identifiants

pubmed: 34284677
doi: 10.1177/09612033211034234
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1739-1746

Auteurs

Shiori Nakagawa (S)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Tadashi Toyama (T)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Innovative Clinical Research Center, Kanazawa University Hospital, Kanazawa, Japan.

Yasunori Iwata (Y)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Megumi Oshima (M)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Hisayuki Ogura (H)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Koichi Sato (K)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Yuta Yamamura (Y)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Taro Miyakawa (T)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Shinji Kitajima (S)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Akinori Hara (A)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
Department of Public Health, Kanazawa University, Kanazawa, Japan.

Norihiko Sakai (N)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Miho Shimizu (M)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Takashi Wada (T)

Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH